✦ LIBER ✦

Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study

✍ Scribed by Uitdehaag, B.; Constantinescu, C.; Cornelisse, P.; Jeffery, D.; Kappos, L.; Li, D.; Sandberg-Wollheim, M.; Traboulsee, A.; Verdun, E.; Rivera, V.

Book ID: 127153177
Publisher: SAGE Publications
Year: 2011
Tongue: English
Weight: 184 KB
Volume: 4
Category: Article
ISSN: 1756-2856
DOI: 10.1177/1756285610391693

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FP39-WE-02 A 15-year follow-up study to

FP39-WE-02 A 15-year follow-up study to identify early predictors of long-term response to intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis

✍ R.A. Bermel; R.A. Rudick; R. Hyde; B. Weinstock-Guttman; D. Bourdette; A. Pace; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

0564 Long-term sustained efficacy and sa

0564 Long-term sustained efficacy and safety of subcutaneous (Sc) interferon beta-1a in patients with relapsing-remitting multiple sclerosis (RRMS): The PRISMS 7–8 year results

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Further study on the specificity and inc

Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b

✍ Guido Antonelli; Eleonora Simeoni; Francesca Bagnato; Carlo Pozzilli; Ombretta T 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 66 KB